Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of AnGes MG, Inc. patents

Patents where

Current Assignee

Name

‌

AnGes MG, Inc.

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7595301 Staple type oligonucleotide and drug comprising the same	Patent 7595301 was granted and assigned to AnGes MG, Inc. on September, 2009 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	7595301	September 29, 2009
‌ US Patent 7504098 Method for introducing a biological molecule using a viral envelope and heparin and system therefore	Patent 7504098 was granted and assigned to AnGes MG, Inc. on March, 2009 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	7504098	March 17, 2009
‌ US Patent 7524830 Decoy-containing pharmaceutical compositions and method of using the same	Patent 7524830 was granted and assigned to AnGes MG, Inc. on April, 2009 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	7524830	April 28, 2009
‌ US Patent 7390482 Drug for auditory dysfunction	Patent 7390482 was granted and assigned to AnGes MG, Inc. on June, 2008 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	7390482	June 24, 2008
‌ US Patent 7279333 Virus envelope vector for gene transfer	Patent 7279333 was granted and assigned to AnGes MG, Inc. on October, 2007 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	7279333	October 9, 2007
‌ US Patent 7247620 Method of treating skin wounds with vectors encoding hepatocyte growth factor	Patent 7247620 was granted and assigned to AnGes MG, Inc. on July, 2007 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	7247620	July 24, 2007
‌ US Patent 7285540 Medicament comprising HGF gene	Patent 7285540 was granted and assigned to AnGes MG, Inc. on October, 2007 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	7285540	October 23, 2007
‌ US Patent 7345158 Actin related cytoskeletal protein “LACS”	Patent 7345158 was granted and assigned to AnGes MG, Inc. on March, 2008 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	7345158	March 18, 2008
‌ US Patent 8969311 Polypeptide having antibacterial activity and angiogenesis-inducing activity and wound-healing drug containing said polypeptide	Patent 8969311 was granted and assigned to AnGes MG, Inc. on March, 2015 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	8969311	March 3, 2015
‌ US Patent 7871983 Remedy and preventive for diseases caused by NF-κB	Patent 7871983 was granted and assigned to AnGes MG, Inc. on January, 2011 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	7871983	January 18, 2011
‌ US Patent 9012417 Topical administration of NF-kappaB decoy to treat atopic dermatitis	Patent 9012417 was granted and assigned to AnGes MG, Inc. on April, 2015 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	9012417	April 21, 2015
‌ US Patent 7790692 Hepatocyte growth factor nucleic acid sequence to enhance musculocutaneous flap survival	Patent 7790692 was granted and assigned to AnGes MG, Inc. on September, 2010 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	7790692	September 7, 2010
‌ US Patent 7994151 Compositions and methods for angiogenic therapy utilizing genes encoding ets-1	Patent 7994151 was granted and assigned to AnGes MG, Inc. on August, 2011 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	7994151	August 9, 2011
‌ US Patent 8067384 Chimera (double) decoy	Patent 8067384 was granted and assigned to AnGes MG, Inc. on November, 2011 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	8067384	November 29, 2011
‌ US Patent 8067388 Decoy-containing pharmaceutical compositions and method of using the same	Patent 8067388 was granted and assigned to AnGes MG, Inc. on November, 2011 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	8067388	November 29, 2011
‌ US Patent 8647820 Circular dumbbell decoy oligodeoxynucleotides (CDODN) containing DNA bindings sites of transcription	Patent 8647820 was granted and assigned to AnGes MG, Inc. on February, 2014 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	8647820	February 11, 2014
‌ US Patent 7803621 Virus envelope vector for gene transfer	Patent 7803621 was granted and assigned to AnGes MG, Inc. on September, 2010 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	7803621	September 28, 2010
‌ US Patent 7763591 Hepatocyte growth factor gene therapy for parkinson's disease	Patent 7763591 was granted and assigned to AnGes MG, Inc. on July, 2010 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	7763591	July 27, 2010
‌ US Patent 7259149 Methods for treating or preventing angiogenesis-dependent symptoms	Patent 7259149 was granted and assigned to AnGes MG, Inc. on August, 2007 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	7259149	August 21, 2007
‌ US Patent 8470765 Polypeptides and antibacterial or antiseptic use of same	Patent 8470765 was granted and assigned to AnGes MG, Inc. on June, 2013 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	8470765	June 25, 2013
‌ US Patent 7939504 Method of treating skin ulcers with vectors encoding hepatocyte growth factor	Patent 7939504 was granted and assigned to AnGes MG, Inc. on May, 2011 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	7939504	May 10, 2011
‌ US Patent 6913923 Virus envelope vector for gene transfer	Patent 6913923 was granted and assigned to AnGes MG, Inc. on July, 2005 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	6913923	July 5, 2005
‌ US Patent 6989374 Gene therapy for cardiomyopathy	Patent 6989374 was granted and assigned to AnGes MG, Inc. on January, 2006 by the United States Patent and Trademark Office.	‌ AnGes MG, Inc.	United States Patent and Trademark Office	6989374	January 24, 2006

23 results

0 selected

23 results

0 selected